(mean 6.3); 82 patients were randomized to memantine (10 mg/day) and 84 were randomized to placebo. Overall outcomes significantly favored the treatment group on measures of global assessment and ...

final approval from the USFDA for Memantine hydrochloride tablets USP, 5 mg and 10 mg," the pharmaceuticals and life sciences company said in its filing. Advisory Alert: It has come to our ...